en

PRODUCT DETAIL

TAKHZYRO 150 mg injekčný roztok v naplnenej injekčnej striekačke

Code 5041E
MA number EU/1/18/1340/009
Product Form: sol iru 6 (3x2)x150 mg (striek.inj.napl.skl. - multibal.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 87 - VARIA I
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B06 OTHER HEMATOLOGICAL AGENTS
B06A OTHER HEMATOLOGICAL AGENTS
B06AC Drugs used in hereditary angioedema
B06AC05 Lanadelumab
Shelf life: 24
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 22.11.2018
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 24.11.2023
eu-flag.png sk-flag.png